Donna Bergen to Anticonvulsants
This is a "connection" page, showing publications Donna Bergen has written about Anticonvulsants.
Connection Strength
1.318
-
Women with epilepsy. Clin Neuropharmacol. 2000 Mar-Apr; 23(2):63-8.
Score: 0.174
-
Restrictions on the availability of antiepileptic drugs. Arch Neurol. 2000 Feb; 57(2):273-4.
Score: 0.174
-
Special report from the World Federation of Neurology. The worldwide impact of new drugs: development, distribution, and use. Epilepsia. 1997 Sep; 38(9):1050-3.
Score: 0.147
-
Incontinence during treatment with gabapentin. Neurology. 1997 May; 48(5):1467-8.
Score: 0.143
-
Undue regulatory control on phenobarbital--an important yet overlooked reason for the epilepsy treatment gap. Epilepsia. 2015 Apr; 56(4):659-62.
Score: 0.124
-
Weight loss in patients taking felbamate. Clin Neuropharmacol. 1995 Feb; 18(1):23-7.
Score: 0.123
-
Reduction of sexual activities in females taking antiepileptic drugs. Psychopathology. 1992; 25(1):1-4.
Score: 0.099
-
Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. Epilepsy Res. 2004 Nov; 62(1):1-11.
Score: 0.060
-
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004 May; 45(5):410-23.
Score: 0.058
-
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004 Apr 27; 62(8):1252-60.
Score: 0.058
-
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004 Apr 27; 62(8):1261-73.
Score: 0.058
-
Safety of Diastat when given at larger-than-recommended doses for acute repetitive seizures. Neurology. 2001 Apr 24; 56(8):1112.
Score: 0.047
-
Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology. 1993 Nov; 43(11):2284-91.
Score: 0.028
-
Medically intractable temporal lobe epilepsy in patients with normal MRI: surgical outcome in twenty-one consecutive patients. Seizure. 2011 Jul; 20(6):475-9.
Score: 0.023